Evidence map›Paper›PMID 23288328›Full record

ArticleBrain : a journal of neurology2013

ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.

Sebahattin Cirak, Aileen Reghan Foley, Ralf Herrmann, Tobias Willer, Shu Yau, Elizabeth Stevens, Silvia Torelli, Lina Brodd, Alisa Kamynina, Petr Vondracek and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Guideline
  2. Pediatric investigation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The genomics of ecological flexibility, large brains, and long lives in capuchin monkeys revealed with fecalFACS.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Case Report:Frontiers in pediatrics · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 14 institutions in 6 countries.

Sebahattin CirakDubowitz Neuromuscular Centre, UCL Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK.
Aileen Reghan Foley
Ralf Herrmann
Tobias Willer
Shu Yau
Elizabeth Stevens
Silvia Torelli
Lina Brodd
Alisa Kamynina
Petr Vondracek
Helen Roper
Cheryl Longman
Rudolf Korinthenberg
Gianni Marrosu
Peter Nürnberg
UK10K Consortium
Daniel E Michele
Vincent Plagnol
Matt Hurles
Steven A Moore
Caroline A Sewry
Kevin P Campbell
Thomas Voit
Francesco Muntoni
University College London · GBGuy's Hospital · GBUniversity of Iowa · USCentre de Recherche en MyologieHeartlands Hospital · GBHoward Hughes Medical Institute · USStobhill Hospital · GBUniversity Hospital Brno · CZUniversity of Cagliari · ITUniversity of Cologne · DEUniversity of Freiburg · DEUniversity of Michigan · USWellcome Sanger Institute · GBZentrum für Kinderheilkunde · DE

Funding

Therapeutic Potential of ESC-Derived Myogenic PrecursorsU54NS053672 · NINDS · UNIVERSITY OF IOWA · PI CAMPBELL, KEVIN P. · 2005 to 2019
$22.0M
Medical Research Council MR/K000608/1NINDS NIH HHS U54 NS053672Wellcome Trust 091310
6 · The paper itself

Abstract

Dystroglycanopathies are a clinically and genetically diverse group of recessively inherited conditions ranging from the most severe of the congenital muscular dystrophies, Walker-Warburg syndrome, to mild forms of adult-onset limb-girdle muscular dystrophy. Their hallmark is a reduction in the functional glycosylation of α-dystroglycan, which can be detected in muscle biopsies. An important part of this glycosylation is a unique O-mannosylation, essential for the interaction of α-dystroglycan with extracellular matrix proteins such as laminin-α2. Mutations in eight genes coding for proteins in the glycosylation pathway are responsible for ∼50% of dystroglycanopathy cases. Despite multiple efforts using traditional positional cloning, the causative genes for unsolved dystroglycanopathy cases have escaped discovery for several years. In a recent collaborative study, we discovered that loss-of-function recessive mutations in a novel gene, called isoprenoid synthase domain containing (ISPD), are a relatively common cause of Walker-Warburg syndrome. In this article, we report the involvement of the ISPD gene in milder dystroglycanopathy phenotypes ranging from congenital muscular dystrophy to limb-girdle muscular dystrophy and identified allelic ISPD variants in nine cases belonging to seven families. In two ambulant cases, there was evidence of structural brain involvement, whereas in seven, the clinical manifestation was restricted to a dystrophic skeletal muscle phenotype. Although the function of ISPD in mammals is not yet known, mutations in this gene clearly lead to a reduction in the functional glycosylation of α-dystroglycan, which not only causes the severe Walker-Warburg syndrome but is also a common cause of the milder forms of dystroglycanopathy.

Indexed as

MutationAdolescentChildChild, PreschoolDystroglycansFemaleGlycosylationHumansMagnetic Resonance ImagingMaleMuscle, SkeletalMuscular DystrophiesMuscular Dystrophies, Limb-GirdleNucleotidyltransferasesYoung AdultCRPPA protein, humanDystroglycansNucleotidyltransferases

Identifiers

PMID23288328
PMCPMC3562076
OpenAlexW2115329421

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.